About Threshold Pharm
Threshold Pharm was a Healthcare company based in San Francisco (United States) founded in 2001 by George Tidmarsh. It develops innovative technologies for targeted cancer therapeutics. It operates on a B2B model. Threshold Pharm has raised $49.25 million across 4 funding rounds from investors including FirstMark, Morgenthaler and CHL Medical Partners. The company has 26 employees. The company is recorded as dissolved. Its focus areas include Biotechnology, Oncology and Targeted Therapeutics. Its legal entity is MOLECULAR TEMPLATES, INC. Its competitors include Insitro, BridgeBio and Forge Biologics; 3 of its 3 listed competitors have raised funding.
Company details
Threshold Pharm, established in 2001 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, oncology, and targeted therapeutics. Develops innovative technologies for targeted cancer therapeutics. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters San Francisco, United States
- Employees 26
- Founders George Tidmarsh
- Stage Public
- SectorsHealthcare
- Website thresholdpharm.com
- Legal Name Molecular Templates, Inc
- Total Equity Funding$49.25M (USD)
in 4 rounds
- Latest Funding Round$35M (USD), Post-IPO
Oct 2009
- InvestorsFirstMark
& 6 more
- Employee Count26
Funding Insights of Threshold Pharm
Threshold Pharm has successfully raised a total of $49.25M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $35 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.25M
- Total Rounds 4
- Last Round Post-IPO — $35M
- First Round $8.25M
(Aug 2003)
- Investors Count 7
All 4 funding rounds of Threshold Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2009 | $35M | Post-IPO | – | – | – |
| Sep 2008 | $18.3M | Post-IPO | – | – | – |
| Jan 2004 | $41M | Series B | – | – | |
| Aug 2003 | $8.25M | Series A | – | – | – |
7 investors in total: 7 institutional.
Investors in Threshold Pharm
Threshold Pharm has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include FirstMark, Morgenthaler and CHL Medical Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity investment firm | morgenthaler.com | Portola Valley, United States | ||
Early-stage venture capital is invested in tech startups across sectors. | 1987 | firstmark.com | New York, United States | |
Early stage healthcare services investments are facilitated by CHL. | chlmedical.com | Westport, United States | ||
Life science & tech focused VC firm investing in companies in the US | threearchpartners.com | San Mateo, United States | ||
Biotech funding, drug development support, and investment in life sciences. | sofinnova.com | |||
| proquestvc.com | ||||
VC firm investing in the US | shv.com | Palo Alto, United States |
Investor details for Threshold Pharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Threshold Pharm
1 people are tracked at Threshold Pharm (1 in leadership); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
George Tidmarsh | Founder | Leadership |
Complete people profiles for Threshold Pharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Threshold Pharm
4 dated milestones of Threshold Pharm across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Threshold Pharm is founded.
- Funding First funding round of $8.2M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $35.0M.
Competitors of Threshold Pharm
Threshold Pharm has 3 listed competitors in our database, 3 of them funded. They include Insitro, BridgeBio and Forge Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| forgebiologics.com | 2020 | Columbus, United States | $250M | 118 | Gene therapies for rare diseases are developed to treat patients. |
Detailed competitors of Threshold Pharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Threshold Pharm
Websites that share an audience with Threshold Pharm (thresholdpharm.com).
Websites whose visitors overlap most with Threshold Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioseekinc.com | 100% | View details | |||
| osip.com | 100% | View details | |||
| pherin.com | 100% | View details | |||
| telik.com | 98% | View details | |||
| affymax.com | 94% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Threshold Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Threshold Pharm (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Threshold Pharm
Complete news archive for Threshold Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Threshold Pharm
Threshold Pharm was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Threshold Pharm is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Threshold Pharm is a funded company, having raised a total of $49.25M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.25M, raised on Aug 2003.
Threshold Pharm has 26 employees.
Threshold Pharm, established in 2001 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, oncology, and targeted therapeutics. Develops innovative technologies for targeted cancer therapeutics. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Threshold Pharm's top competitors include BridgeBio, Forge Biologics and Insitro.
Threshold Pharm has 7 investors. Key investors include FirstMark, Morgenthaler, CHL Medical Partners, Three Arch Partners, and Sofinnova.
Threshold Pharm operates through Molecular Templates, Inc.